Global Pimozide Market Research Report 2012-2024
- HEY3200504
- 65 Pages
- June 2019
- Medical Devices
Pimozide (sold under the brand name Orap) is an antipsychotic drug of the diphenylbutylpiperidine class. It was discovered at Janssen Pharmaceutica in 1963. It has a high potency compared to chlorpromazine (ratio 50-70:1). On a weight basis it is even more potent than haloperidol. It also has special neurologic indications for Tourette syndrome and resistant tics. The side effects include akathisia, tardive dyskinesia, and, more rarely, neuroleptic malignant syndrome and prolongation of the QT interval.
The global Pimozide market will reach xxx Million USD in 2019 with CAGR xx% 2019-2024. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.
Based on products type, the report describes major products type share of regional market. Products mentioned as follows:
1Mg
2Mg
4Mg
Leading vendors in the market are included based on profile, business performance etc. Vendors mentioned as follows:
Teva
Par Pharmaceutical
Johnson & Johnson
Eumedica
Pharmascience
Domina Pharmaceuticals
Aa Pharma
Based on Application, the report describes major application share of regional market. Application mentioned as follows:
Hospitals
Drugstores
Others
Based on region, the report describes major regions market by products and application. Regions mentioned as follows:
Asia-Pacific
North America
Europe
South America
Middle East & Africa
1 Market Overview
1.1 Objectives of Research
1.1.1 Definition
1.1.2 Specifications
1.2 Market Segment
1.2.1 by Type
1.2.1.1 1Mg
1.2.1.2 2Mg
1.2.1.3 4Mg
1.2.2 by Application
1.2.2.1 Hospitals
1.2.2.2 Drugstores
1.2.2.3 Others
1.2.3 by Regions
2 Industry Chain
2.1 Industry Chain Structure
2.2 Upstream
2.3 Market
2.3.1 SWOT
2.3.2 Dynamics
3 Environmental Analysis
3.1 Policy
3.2 Economic
3.3 Technology
3.4 Market Entry
4 Market Segmentation by Type
4.1 Market Size
4.1.1 1Mg Market, 2013-2018
4.1.2 2Mg Market, 2013-2018
4.1.3 4Mg Market, 2013-2018
4.2 Market Forecast
4.2.1 1Mg Market Forecast, 2019-2024
4.2.2 2Mg Market Forecast, 2019-2024
4.2.3 4Mg Market Forecast, 2019-2024
5 Market Segmentation by Application
5.1 Market Size
5.1.1 Hospitals Market, 2013-2018
5.1.2 Drugstores Market, 2013-2018
5.1.3 Others Market, 2013-2018
5.2 Market Forecast
5.2.1 Hospitals Market Forecast, 2019-2024
5.2.2 Drugstores Market Forecast, 2019-2024
5.2.3 Others Market Forecast, 2019-2024
6 Market Segmentation by Region
6.1 Market Size
6.1.1 Asia-Pacific
6.1.1.1 Asia-Pacific Market, 2012-2018
6.1.1.2 Asia-Pacific Market by Type
6.1.1.3 Asia-Pacific Market by Application
6.1.2 North America
6.1.2.1 North America Market, 2012-2018
6.1.2.2 North America Market by Type
6.1.2.3 North America Market by Application
6.1.3 Europe
6.1.3.1 Europe Market, 2012-2018
6.1.3.2 Europe Market by Type
6.1.3.3 Europe Market by Application
6.1.4 South America
6.1.4.1 South America Market, 2012-2018
6.1.4.2 South America Market by Type
6.1.4.3 South America Market by Application
6.1.5 Middle East & Africa
6.1.5.1 Middle East & Africa Market, 2012-2018
6.1.5.2 Middle East & Africa Market by Type
6.1.5.3 Middle East & Africa Market by Application
6.2 Market Forecast
6.2.1 Asia-Pacific Market Forecast, 2019-2024
6.2.2 North America Market Forecast, 2019-2024
6.2.3 Europe Market Forecast, 2019-2024
6.2.4 South America Market Forecast, 2019-2024
6.2.5 Middle East & Africa Market Forecast, 2019-2024
7 Market Competitive
7.1 Global Market by Vendors
7.2 Market Concentration
7.3 Price & Factors
7.4 Marketing Channel
8 Major Vendors
8.1 Teva
8.2 Par Pharmaceutical
8.3 Johnson & Johnson
8.4 Eumedica
8.5 Pharmascience
8.6 Domina Pharmaceuticals
8.7 Aa Pharma
9 Conclusion
Table Products Segment of Pimozide
Table 1Mg Overview
Table 2Mg Overview
Table 4Mg Overview
Table Global Pimozide Market by Type, 2011-2022 (USD Million)
Table Application Segment of Pimozide
Table Hospitals Overview
Table Drugstores Overview
Table Others Overview
Table Global Pimozide Market by Application, 2011-2022 (USD Million)
Table Global Pimozide Market by Region, 2011-2022 (USD Million)
Table Cost of Pimozide
Table Market Dynamics
Table Policy of Pimozide
Table GDP of Major Countries
Table 1Mg CAGR by Revenue and Volume, 2012-2018
Table 2Mg CAGR by Revenue and Volume, 2012-2018
Table 4Mg CAGR by Revenue and Volume, 2012-2018
Table 1Mg CAGR by Revenue and Volume, 2012-2024
Table 2Mg CAGR by Revenue and Volume, 2012-2024
Table 4Mg CAGR by Revenue and Volume, 2012-2024
Table Hospitals CAGR by Revenue and Volume, 2012-2018
Table Drugstores CAGR by Revenue and Volume, 2012-2018
Table Others CAGR by Revenue and Volume, 2012-2018
Table Global Pimozide Market by Vendors, 2012-2018 (USD Million)
Table Global Pimozide Market by Vendors, 2012-2018 (in Volume)
Table Global Pimozide Market Share by Vendors, 2012-2018 (USD Million)
Table Global Pimozide Market Share by Vendors, 2012-2018 (in Volume)
Table Price Factors List
Table Teva Profile List
Table Microecological Modulator Operating Data of Teva (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Par Pharmaceutical Profile List
Table Microecological Modulator Operating Data of Par Pharmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Johnson & Johnson Profile List
Table Microecological Modulator Operating Data of Johnson & Johnson (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Eumedica Profile List
Table Microecological Modulator Operating Data of Eumedica (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Pharmascience Profile List
Table Microecological Modulator Operating Data of Pharmascience (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Domina Pharmaceuticals Profile List
Table Microecological Modulator Operating Data of Domina Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Aa Pharma Profile List
Table Microecological Modulator Operating Data of Aa Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Similar Reports
This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by Application, 2019-2023, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
This report provides an overview of the German molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
This report provides an overview of the Italian molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
